|
[1]Valla D.Hepatic venous outflow tract obstruction etipatho-genesis:Asia versus the West[J].J Gastroenterol Hepatol, 2004, 19 (Suppl 7) :S204-S211.
|
|
[2]Denninger MH, Chait Y, Casadevall N, et al.Cause of portalor hepatic venous thrombosis in adults:the role of multipleconcurrent factors[J].Hepatology, 2000, 31 (3) :587-591.
|
|
[3] 李艳奎, 张小明, 沈晨阳, 等.膜性梗阻型布一加综合征隔膜和机化血栓组织中相关细胞因子表达的研究[J].中华普通外科杂志, 2008, 23 (8) :618-621.
|
|
[4]Noone TC, Semelka RC, Siegelman ES, et al.Budd-Chiarisyndrome:spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging[J].JMagn Reson Imaging, 2000, 11 (1) :44-50.
|
|
[5]Laurie D.DeLeve, Dominique-Charles Valla, Guadalupe Garcia-Tsao.Vascular Disorders of the Liver[J].Hepatology, 2009, 49:1729-1764.
|
|
[6]Giuseppe B, Valérie V, Michael PF, et al.Budd-Chiari Syn-drome:Spectrum of Imaging Findings[J].American Roent-gen Ray Society, 2007, 188 (2) :W168-W176.
|
|
[7]Sharma S, Texeira A, Texeira P, et al.Pharmacological throm-bolysis in Budd Chiari syndrome:A single centre experience andreview of the literature[J].J Hepatol, 2004, 40 (1) :172-180.
|
|
[8]Mancuso A, Fung K, Mela M, et al.TIPS for acute andchronic Budd-Chiari syndrome:A single-centre experi-ence[J].J Hepatol, 2003, 38 (6) :751-754.
|
|
[9]DeLeve LD, Shulman HM, McDonald GB.Toxic injury to he-patic sinusoids:sinusoidal obstruction syndrome (veno-oc-clusive disease) [J].Semin Liver Dis, 2002, 22 (1) :27-42.
|
|
[10]Lee JL, Gooley T, Bensinger W, et al.Venocclusive diseaseof the liver after high-dose chemotherapy with alkylating a-gents:incidence, outcome and risk fac-tors[J].Hepatolo-gy, 1997, 26:149A.
|
|
[11]Laura Rubbia-Brandt.Sinusoidal Obstruction Syndrome[J].Clin Liver Dis, 2010, 14 (4) :651-668.
|
|
[12]Dickinson AM, Holler E.Polymorphisms of cytokine and in-nate immunity genes and GVHD[J].Best Pract Res ClinHaematol, 2008, 21 (2) :149-164.
|
|
[13]Schots R, Kaufman L, Van Riet I, et al.Proinflammatory cy-tokines and their role in the development of major transplant-related complications in the early phase after allogeneicbone marrow transplantation[J].Leukemia, 2003, 17 (6) :1150-1156.
|
|
[14]Rubbia-Brandt L, Lauwers GY, Wuang H, et al.Sinusoidalobstruction syndrome and nodular regenerative hyperplasiaare frequent oxaliplatin associated liver lesions and partiallyprevented by bevacizumab in patients with hepatic colorectalmetastasis[J].Histopathology, 2010, 56 (4) :430-439.
|
|
[15]Jevtic D, Vujic D, Zecevic Z, et al.Coagulation disturbancesin paediatric patients with hepatic veno-occlusive diseaseafter stem cells transplantation[J].Srp Arh Celok Uk, 2010, 138 (Suppl 1) :33-38.
|
|
[16]梁扩寰.肝脏病学[M].北京:人民卫生出版社, 2003:1111-1115.
|
|
[17]McCarville MB, Hoffer FA, Howard SC, et al.Hepatic veno-occlusive disease in children undergoing bone-marrowtransplantation:usefulness of sonographic findings[J].Ped-iatr Radiol, 2001, 31 (2) :102-105.
|
|
[18]Shulman HM, Gooley T, Dudley MD, et al.Utility of trans-venous liver biopsies and wedged hepatic venous pressuremeasurements in sixty marrow transplant recipients[J].Transplantation, 1995, 59 (7) :1015-1122.
|
|
[19]Carreras E, Granena A, Navasa M, et al.On the reliability ofclinical criteria for the diagnosis of hepatic veno-occlusivedisease[J].Ann Hematol, 1993, 66 (2) :77-80.
|
|
[20]Bearman SI.The syndrome of hepatic veno-occlusive dis-ease after marrow transplantation[J].Blood, 1995 (11) , 85:3005-3020.
|
|
[21]Bearman SI, Lee JL, Baron AE, et al.Treatment of hepaticvenocclusive disease with recombinant human tissue plas-minogen activator and heparin in 42 marrow transplant pa-tients[J].Blood, 1997, 89 (5) :1501-1506.
|
|
[22]Chen IL, Yang SN, Hsiao CC, et al.Treatment with high-dose methylprednisolone for hepatic veno-occlusive diseasein a child with rhabdomyosarcoma[J].Pediatr Neonatol, 2008, 49 (4) :141-144.
|
|
[23]Akyüz C, CaClar K, Emir S, et al.High-dose methylpred-nisolone treatment of hepatic veno-occlusive disease in achild with Wilms tumor[J].Pediatr Hematol Oncol, 2003, 20 (4) :345-349.
|
|
[24]Chanlandon Y, Roosnek E, Helg C, et al.Efficient prophy-laxis with defibrotide for hepatic veno-occlusive disease af-ter allogeneic stem cell transplantation (SCT) [J].Blood, 2002, 100:111a.
|
|
[25]Helmy A.updates in the pathogenesis and therapy of hepaticsinusoidal obstruction syndrome[J].Aliment Pharmacol T-her, 2006, 23 (1) :11-25.
|
DownLoad: